🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fiyinfolu Balogun

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0003-4703-1560

Also affiliated with Cornell University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice

(2023)10.1158/1078-0432.c.6532713.v1
Top 100%
0DataRank
Top 100%0 citations

Catherine O’Connor, Chaitanya Bandlamudi, Daniella Forman, Joanne F. Chou, Shigeaki Umeda +11 more

Papers

Driven by 8 papers — median percentile 0. Top paper: “Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival”.

Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival

Nature Medicine(2025)10.1038/s41591-024-03362-3
N/A
0.659DataRank · unranked
80 citations

Maria Perry, Joanne F. Chou, Subhiksha Nandakumar, Daniel M. Muldoon, Amanda Erakky +24 more

Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1483
N/A
0.546DataRank · unranked
37 citations

Catherine O’Connor, Chaitanya Bandlamudi, Daniella Forman, Joanne F. Chou, Shigeaki Umeda +11 more

Phase 2 trial of pembrolizumab and olaparib (POLAR) maintenance for patients (pts) with metastatic pancreatic cancer (mPDAC): Two cohorts B non-core homologous recombination deficiency (HRD) and C exceptional response to platinum-therapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4140
N/A
0.449DataRank · unranked
19 citations

Catherine O’Connor, Joanne F. Chou, Carly Schwartz, Anna M. Varghese, Mary Pat Larsen +15 more

Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae095
N/A
0.373DataRank · unranked
11 citations

Joanne F. Chou, Henry Walch, Joshua D. Schoenfeld, Anupriya Singhal, Darren Cowzer +12 more

Clinical utility and tissue concordance of circulating tumor DNA in pancreatic ductal adenocarcinoma

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf139
N/A
0.241DataRank · unranked
4 citations

Lily V. Saadat, Catherine O’Connor, Joanne F. Chou, Anita S. Bowman, Fei Xu +18 more

Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial

Research Square(2025)10.21203/rs.3.rs-7334701/v1
N/A
0.214DataRank · unranked
3 citations

Catherine O’Connor, Joanne F. Chou, Marc Hilmi, Zeynep Tarcan, Carly Schwartz +61 more

Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae269
N/A
0DataRank · unranked
3 citations

Catherine O’Connor, Drew Moss, Joanne F. Chou, Maria Perry, Fionnuala Crowley +26 more

Data from Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice

(2023)10.1158/1078-0432.c.6532713.v1
Top 100%
0DataRank
Top 100%0 citations

Catherine O’Connor, Chaitanya Bandlamudi, Daniella Forman, Joanne F. Chou, Shigeaki Umeda +11 more